These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1690288)

  • 21. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
    Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic T-cell epitopes in HIV/SIV infection.
    Venet A; Walker BD
    AIDS; 1993; 7 Suppl 1():S117-26. PubMed ID: 7689848
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of HIV-2 and SIVSM infection in cynomolgus monkeys by active or passive immunization.
    Biberfield G; Putkonen P; Thorstensson R; Norrby E
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1511-3. PubMed ID: 1466992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles.
    Willey RL; Byrum R; Piatak M; Kim YB; Cho MW; Rossio JL; Bess J; Igarashi T; Endo Y; Arthur LO; Lifson JD; Martin MA
    J Virol; 2003 Jan; 77(2):1163-74. PubMed ID: 12502833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.
    Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G
    J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral immunity to HIV, SIV, and SHIV.
    Haigwood NL; Zolla-Pazner S
    AIDS; 1998; 12 Suppl A():S121-32. PubMed ID: 9632993
    [No Abstract]   [Full Text] [Related]  

  • 27. Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen.
    Hel Z; Tsai WP; Thornton A; Nacsa J; Giuliani L; Tryniszewska E; Poudyal M; Venzon D; Wang X; Altman J; Watkins DI; Lu W; von Gegerfelt A; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
    J Immunol; 2001 Dec; 167(12):7180-91. PubMed ID: 11739541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-protection against mucosal simian immunodeficiency virus (SIVsm) challenge in human immunodeficiency virus type 2-vaccinated cynomolgus monkeys.
    Walther-Jallow L; Nilsson C; Söderlund J; Ten Haaft P; Mäkitalo B; Biberfeld P; Böttiger P; Heeney J; Biberfeld G; Thorstensson R
    J Gen Virol; 2001 Jul; 82(Pt 7):1601-1612. PubMed ID: 11413371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.
    Daniel MD; Kirchhoff F; Czajak SC; Sehgal PK; Desrosiers RC
    Science; 1992 Dec; 258(5090):1938-41. PubMed ID: 1470917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
    Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
    Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of SIV/deltaB670 glycoprotein-enriched and glycoprotein-depleted subunit vaccines in protecting against infection and disease in rhesus monkeys.
    Murphey-Corb M; Montelaro RC; Miller MA; West M; Martin LN; Davison-Fairburn B; Ohkawa S; Baskin GB; Zhang JY; Miller GB
    AIDS; 1991 Jun; 5(6):655-62. PubMed ID: 1883540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole inactivated SIV vaccine grown on human cells fails to protect against homologous SIV grown on simian cells.
    Putkonen P; Nilsson C; Hild K; Benthin R; Cranage M; Aubertin AM; Biberfeld G
    J Med Primatol; 1993; 22(2-3):100-3. PubMed ID: 8411101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV vaccine development: current status and future challenges.
    Koff WC
    Biotechnol Ther; 1991; 2(1-2):195-203. PubMed ID: 1845121
    [No Abstract]   [Full Text] [Related]  

  • 34. No evidence for the contamination of live oral poliomyelitis vaccines with simian immunodeficiency virus.
    Ohta Y; Tsujimoto H; Ishikawa K; Yamamoto H; Doi Y; Honjo S; Arita M; Hayami M
    AIDS; 1989 Mar; 3(3):183-5. PubMed ID: 2540773
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated immune response of macaques immunized with low doses of simian immunodeficiency virus (SIV).
    Dittmer U; Spring M; Petry H; Nisslein T; Rieckmann P; Lüke W; Stahl-Hennig C; Hunsmann G; Bodemer W
    J Biotechnol; 1996 Jan; 44(1-3):105-10. PubMed ID: 8717393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current approaches to vaccination against human immunodeficiency viruses.
    Gluckman JC; Yagello M; Bahraoui E; Girard M
    Allergol Immunopathol (Madr); 1991; 19(1):11-3. PubMed ID: 1719790
    [No Abstract]   [Full Text] [Related]  

  • 38. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
    Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
    J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of simian immunodeficiency viruses for AIDS research.
    Desrosiers RC; Ringler DJ
    Intervirology; 1989; 30(6):301-12. PubMed ID: 2559900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SIV and FIV vaccine studies at UC Davis: 1991 update.
    Gardner M; Yamamoto J; Marthas M; Miller C; Jennings M; Rosenthal A; Luciw P; Planelles V; Yilma T; Giavedoni L
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1495-8. PubMed ID: 1334682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.